Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Paris - Delayed Quote EUR

PHAXIAM Therapeutics S.A. (PHXM.PA)

Compare
0.6900
+0.0120
+(1.77%)
At close: April 15 at 5:35:16 PM GMT+2

Research Analysis

Revenue vs. Earnings

Revenue 470k
Earnings -5.14M

Q3'21

Q4'21

Q1'22

Q3'22

-10M
-5M
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

4.90
4.90 Average
0.6900 Current
4.90 High

Earnings Estimate

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (2024)Next Year (2025)
No. of Analysts ----11
Avg. Estimate 00-1.98-0.89
Low Estimate 00-1.98-0.89
High Estimate 00-1.98-0.89
Year Ago EPS -----5.87-1.98

Revenue Estimate

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (2024)Next Year (2025)
No. of Analysts ----11
Avg. Estimate --------
Low Estimate --------
High Estimate --------
Year Ago Sales --------
Sales Growth (year/est) ----0.00%0.00%

EPS Trend

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (2024)Next Year (2025)
Current Estimate 00-1.98-0.89
7 Days Ago 00-1.98-0.75
30 Days Ago 00-1.98-0.72
60 Days Ago 00-1.98-0.81
90 Days Ago 00-1.98-0.84

EPS Revisions

Currency in USD Current Qtr. (Jan 1970)Next Qtr. (Jan 1970)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days ----11
Down Last 30 Days ----11

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
PHXM.PA ----66.26%55.05%
S&P 500 6.76%5.73%9.19%14.14%

Related Tickers